Study Says New Drug Eluxadoline Could Benefit IBS Patients

Massachusetts scientists studying irritable bowel syndrome (IBS) have concluded that the new drug eluxadoline could benefit some patients with this condition. They specifically followed individuals with IBS-D, the diarrhea-predominant form of the disorder.



via Health News Headlines - Yahoo! News http://news.yahoo.com/study-says-drug-eluxadoline-could-benefit-ibs-patients-153900434.html